Soft tissue sarcoma: An overview.
Malignancy of soft tissue, referred to as sarcomas, are some of the rarest tumors in medicine. These tumors account for approximately 1% of all diagnosed malignancies. Diagnosis of soft tissue sarcoma (STS) is a complex process that includes history and physical examination of patient, diagnostic imaging studies, and biopsy when indicated. All clinicians should be able to identify the unique characteristics of malignant soft tissue tumors and assist patients with obtaining care from a specialist in the treatment of STS. Evidence-based medicine has shown that the critical difference in treating STSs is a multidisciplinary approach.
Goldberg
Brynn R
BR
Department of Orthopaedics, Mayo Clinic Arizona, 5777 East Mayo Boulevard, Phoenix, AZ 85259, USA.
D000359:Aftercare; D000671:Amputation, Surgical; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001706:Biopsy; D003131:Combined Modality Therapy; D019317:Evidence-Based Medicine; D006801:Humans; D008279:Magnetic Resonance Imaging; D008487:Medical History Taking; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D024802:Nurse's Role; D009730:Nursing Assessment; D016530:Orthopedic Nursing / Q000458:organization & administration; D010348:Patient Care Team / Q000458:organization & administration; D010808:Physical Examination; D018714:Radiotherapy, Adjuvant; D012509:Sarcoma / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D012983:Soft Tissue Neoplasms / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents